MVK
Mevalonate kinase
Also known as: KIME_HUMAN, LRBP, MK
Cross-references: UniProt · Ensembl · Human Protein Atlas · GeneCards · NCBI Gene
Protein identityUniProt · HPA
- UniProt accession
- Q03426
- Gene
- MVK
- Ensembl
- ENSG00000110921
- Chromosome
- 12
- Canonical length
- 396 aa
- Protein class
- Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins
- Subcellular location
- Vesicles,Cytosol
- Quaternary structure
- Homodimer
OverviewNCBI Gene
This gene encodes the peroxisomal enzyme mevalonate kinase. Mevalonate is a key intermediate, and mevalonate kinase a key early enzyme, in isoprenoid and sterol synthesis. Mevalonate kinase deficiency caused by mutation of this gene results in mevalonic aciduria, a disease characterized psychomotor retardation, failure to thrive, hepatosplenomegaly, anemia and recurrent febrile crises. Defects in this gene also cause hyperimmunoglobulinaemia D and periodic fever syndrome, a disorder characterized by recurrent episodes of fever associated with lymphadenopathy, arthralgia, gastrointestinal dismay and skin rash. Alternative splicing results in multiple transcript variants. [provided by RefSeq, Jul 2014]
Canonical amino-acid sequenceUniProt
396 residues, UniProt reviewed canonical sequence.
>Q03426|MVK
1 MLSEVLLVSA PGKVILHGEH AVVHGKVALA VSLNLRTFLR LQPHSNGKVD LSLPNIGIKR
61 AWDVARLQSL DTSFLEQGDV TTPTSEQVEK LKEVAGLPDD CAVTERLAVL AFLYLYLSIC
121 RKQRALPSLD IVVWSELPPG AGLGSSAAYS VCLAAALLTV CEEIPNPLKD GDCVNRWTKE
181 DLELINKWAF QGERMIHGNP SGVDNAVSTW GGALRYHQGK ISSLKRSPAL QILLTNTKVP
241 RNTRALVAGV RNRLLKFPEI VAPLLTSIDA ISLECERVLG EMGEAPAPEQ YLVLEELIDM
301 NQHHLNALGV GHASLDQLCQ VTRARGLHSK LTGAGGGGCG ITLLKPGLEQ PEVEATKQAL
361 TSCGFDCLET SIGAPGVSIH SATSLDSRVQ QALDGLLocalizationUniProt · AlphaFold · HPA
Whether an antibody against MVK can act on the native protein depends on physical access: surface and secreted proteins are reachable by circulating antibodies, intracellular proteins usually are not.
- Antibody reachability
- Intracellular
- Secreted
- No
- Transmembrane segments
- 0
- Mean surface accessibility (rSASA)
- 0.24
- Highest tissue expression
- 59 nTPM
Expression across tissuesHPA
Tissue
- liver: 59 nTPM
- esophagus: 38 nTPM
- kidney: 28 nTPM
- skin: 25 nTPM
- spinal cord: 25 nTPM
- adrenal gland: 22 nTPM
Single-cell type
- esophageal apical cells: 203 nCPM
- early spermatids: 84 nCPM
- esophageal suprabasal cells: 79 nCPM
- breast lactating cells: 75 nCPM
- retinal horizontal cells: 74 nCPM
- cardiomyocytes: 73 nCPM
Immune cell
- naive B-cell: 11 nTPM
- memory CD8 T-cell: 9.9 nTPM
- gdT-cell: 9.5 nTPM
- naive CD4 T-cell: 8.8 nTPM
- MAIT T-cell: 8.5 nTPM
- NK-cell: 8.4 nTPM
Brain region
- pons: 31 nTPM
- medulla oblongata: 25 nTPM
- white matter: 17 nTPM
- cerebellum: 16 nTPM
- midbrain: 16 nTPM
- spinal cord: 15 nTPM
DiseaseUniProt · ClinVar · IEDB · PubMed
Four sources answering four different questions about MVK.
Disease | AllUniProt
Conditions MVK is implicated in, by any mechanism.
- Mevalonic aciduria (MEVA) MIM:610377
- Hyperimmunoglobulinemia D and periodic fever syndrome (HIDS) MIM:260920
- Porokeratosis 3, multiple types (POROK3) MIM:175900
Disease | GeneticClinVar
112 pathogenic / likely-pathogenic of 796 ClinVar records.
Conditions with pathogenic or likely-pathogenic variants.
- Hyperimmunoglobulin D with periodic fever
- Mevalonic aciduria
- Porokeratosis 3, disseminated superficial actinic type
- MVK-related disorder
- Autoinflammatory syndrome
Genetic constraint and essentialitygnomAD · DepMap
Does the body need this protein intact? Low LOEUF or a strong DepMap dependency means loss or blockade of the protein is likely to be felt.
- gnomAD LOEUF (loss-of-function intolerance)
- 0.55
- gnomAD pLI
- 0.17
- gnomAD missense Z
- 0.94
- DepMap mean gene effect
- -0.78
- DepMap dependency class
- common
Cancer expressionTCGA
Across TCGA tumor cohorts, this protein is over-expressed in roughly 5% of surveyed tumor types (aggregate summary; per-cohort expression, alteration, and survival load in the interactive view).
OntologyGO
Biological processes
- cholesterol biosynthetic process
- isopentenyl diphosphate biosynthetic process, mevalonate pathway
- isoprenoid biosynthetic process
- negative regulation of inflammatory response
Molecular functions
- ATP binding
- identical protein binding
- magnesium ion binding
- mevalonate kinase activity
Cellular components
Protein domainsUniProt · Pfam · InterPro
- GHMP kinase, ATP-binding, conserved site
- GHMP kinase N-terminal domain
- GHMP kinase, C-terminal domain
- Small ribosomal subunit protein uS5 domain 2-type fold, subgroup
- Ribosomal protein uS5 domain 2-type superfamily
- GHMP kinase, C-terminal domain superfamily
- GHMP kinases N terminal domain
- GHMP kinases C terminal
- Mevalonate kinase
KeywordsUniProt
Antibody and autoantibody relevanceSeroatlas analysis
Seroatlas reads MVK as an antibody target. Whether an autoantibody or antibody against MVK could matter depends on whether native MVK is physically reachable, whether the body needs it intact, and whether it acts in a disease-relevant tissue.
MVK is annotated as predominantly intracellular. Intracellular proteins are common autoantibody markers, becoming visible to the immune system after cell injury or altered processing, but are usually markers of disease rather than direct drivers.
Annotation status
The present source text does not explicitly label MVK as an autoantigen. Seroatlas presents hypothesis context only and does not manufacture a known-serology claim.
Loading the interactive Seroatlas protein explorer...